Trillium Therapeutics Inc.

Finance

Trillium Therapeutics Inc. (TRIL) – Don’t Be So Quick to Call it Dead

Richard Addington - February 24, 2021 0

141 institutions hold shares in Trillium Therapeutics Inc. (TRIL), with institutional investors hold 68.87% of the company's shares. The shares outstanding are 100.71M, and...

Markets

A peek at Trillium Therapeutics Inc. (TRIL): Who has invested in It?

Winifred Gerald - February 12, 2021 0

141 institutions hold shares in Trillium Therapeutics Inc. (TRIL), with institutional investors hold 68.87% of the company's shares. The shares outstanding are 100.71M, and...

Markets

Here are the top Institutional holders of Trillium Therapeutics Inc. (TRIL) shares

Winifred Gerald - January 12, 2021 0

Trillium Therapeutics Inc. (NASDAQ: TRIL) is -2.65% lower on its value in year-to-date trading and has touched a low of $1.57 and a high...

Finance

The Premier Stocks For Your Portfolio: Veritone Inc. (VERI), Trillium Therapeutics Inc. (TRIL)

Sue Brooks - September 1, 2020 0

Veritone Inc. (NASDAQ: VERI) shares are 232.13% up in the year-to-date (YTD) period and have moved -4.28% or -$0.37 lower in the latest trading...

News

Stocks that are not receiving major attention: Trillium Therapeutics Inc. (TRIL), Arlo Technologies Inc. (ARLO)

Richard Addington - August 25, 2020 0

Trillium Therapeutics Inc. (NASDAQ: TRIL) shares are 915.53% up in the year-to-date (YTD) period and have moved -4.11% or -$0.43 lower in the latest...

Finance

Which Institutions Own Shares In Trillium Therapeutics Inc. (TRIL)?

Richard Addington - August 10, 2020 0

Trillium Therapeutics Inc. (NASDAQ: TRIL) is 701.94% higher on its value in year-to-date trading and has touched a low of $0.24 and a high...

Trillium Therapeutics Inc.